OCULAR THERAPEUTIX, INC Quarterly Return On Equity in % from Q1 2015 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Ocular Therapeutix, Inc quarterly/annual Return On Equity history and growth rate from Q1 2015 to Q3 2024.
  • Ocular Therapeutix, Inc Return On Equity for the quarter ending September 30, 2024 was -56.8 %, a 88.1% increase year-over-year.
  • Ocular Therapeutix, Inc annual Return On Equity for 2023 was -289 %, a 131% decline from 2022.
  • Ocular Therapeutix, Inc annual Return On Equity for 2022 was -125 %, a 1517% decline from 2021.
  • Ocular Therapeutix, Inc annual Return On Equity for 2021 was -7.73 %, a 99.2% increase from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -56.8 +422 +88.1% Jul 1, 2024 Sep 30, 2024
Q2 2024 -62.6 +322 +83.7% Apr 1, 2024 Jun 30, 2024
Q1 2024 -90.4 +136 +60% Jan 1, 2024 Mar 31, 2024
Q4 2023 -289 -164 -131% Oct 1, 2023 Dec 31, 2023
Q3 2023 -479 -394 -464% Jul 1, 2023 Sep 30, 2023
Q2 2023 -384 -344 -849% Apr 1, 2023 Jun 30, 2023
Q1 2023 -226 -200 -753% Jan 1, 2023 Mar 31, 2023
Q4 2022 -125 -117 -1517% Oct 1, 2022 Dec 31, 2022
Q3 2022 -84.8 +23.2 +21.5% Jul 1, 2022 Sep 30, 2022
Q2 2022 -40.5 +134 +76.8% Apr 1, 2022 Jun 30, 2022
Q1 2022 -26.5 +300 +91.9% Jan 1, 2022 Mar 31, 2022
Q4 2021 -7.73 +926 +99.2% Oct 1, 2021 Dec 31, 2021
Q3 2021 -108 -3.05K -104% Jul 1, 2021 Sep 30, 2021
Q2 2021 -175 +17.3K +99% Apr 1, 2021 Jun 30, 2021
Q1 2021 -326 +6.56K +95.3% Jan 1, 2021 Mar 31, 2021
Q4 2020 -934 -103 -12.4% Oct 1, 2020 Dec 31, 2020
Q3 2020 2.94K +3.32K Jul 1, 2020 Sep 30, 2020
Q2 2020 -17.5K -17.2K -6705% Apr 1, 2020 Jun 30, 2020
Q1 2020 -6.89K -6.72K -4054% Jan 1, 2020 Mar 31, 2020
Q4 2019 -831 -695 -511% Oct 1, 2019 Dec 31, 2019
Q3 2019 -384 -250 -187% Jul 1, 2019 Sep 30, 2019
Q2 2019 -257 -113 -79.1% Apr 1, 2019 Jun 30, 2019
Q1 2019 -166 -12.3 -8.03% Jan 1, 2019 Mar 31, 2019
Q4 2018 -136 +9.64 +6.62% Oct 1, 2018 Dec 31, 2018
Q3 2018 -134 -7.41 -5.87% Jul 1, 2018 Sep 30, 2018
Q2 2018 -143 -42.3 -41.9% Apr 1, 2018 Jun 30, 2018
Q1 2018 -154 -73.3 -91.3% Jan 1, 2018 Mar 31, 2018
Q4 2017 -146 -78.2 -116% Oct 1, 2017 Dec 31, 2017
Q3 2017 -126 -70.1 -125% Jul 1, 2017 Sep 30, 2017
Q2 2017 -101 -48.6 -92.6% Apr 1, 2017 Jun 30, 2017
Q1 2017 -80.3 -34.7 -76.2% Jan 1, 2017 Mar 31, 2017
Q4 2016 -67.5 -22 -48.4% Oct 1, 2016 Dec 31, 2016
Q3 2016 -56.2 -9.7 -20.9% Jul 1, 2016 Sep 30, 2016
Q2 2016 -52.4 -6.44 -14% Apr 1, 2016 Jun 30, 2016
Q1 2016 -45.6 +63.7 +58.3% Jan 1, 2016 Mar 31, 2016
Q4 2015 -45.5 Oct 1, 2015 Dec 31, 2015
Q3 2015 -46.5 Jul 1, 2015 Sep 30, 2015
Q2 2015 -46 Apr 1, 2015 Jun 30, 2015
Q1 2015 -109 Jan 1, 2015 Mar 31, 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.